These results correlate with those of Francardo et al., who demonstrated that treatment by PRE-084 (SIGMAR1 agonist) in a PD pharmacological mouse model rescued pathological behavior and decreased PD biomarkers [56]. The gene discussed is SIGMAR1; the disease is Parkinson disease.